deltatrials
Completed PHASE4 NCT00153530

Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)

Phase IV Study on the Role of Whole Brain Irradiation in Primary CNS Lymphoma (PCNSL) After High-dose Methotrexate

Sponsor: Charite University, Berlin, Germany

Conditions Central Nervous System Lymphoma
Interventions methotrexate radiotherapy
Updated 5 times since 2017 Last updated: Dec 23, 2009 Started: May 31, 2000 Completion: May 31, 2009

Listed as NCT00153530, this PHASE4 trial focuses on Central Nervous System Lymphoma and remains completed. Sponsored by Charite University, Berlin, Germany, it has been updated 5 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

May 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Charite University, Berlin, Germany
  • University Hospital Tuebingen
Data source: Charite University, Berlin, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Berlin, Germany